| 缩写名/全名 |
EXPERT OPIN PHARMACO
EXPERT OPINION ON PHARMACOTHERAPY |
||||||||||||||||||||
| ISSN号 | 1465-6566 | ||||||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||||||
| 影响因子 | 2015:3.543, 2016:3.894, 2017:3.475, 2018:3.038, 2019:2.878, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||
| 年文章数 | 171 | ||||||||||||||||||||
| 出版年份 | 1999 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 偏慢,4-8周 |
||||||||||||||||||||
| 录用比例 | 容易 | ||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/eoop | ||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/loi/ieop20 | ||||||||||||||||||||
| h-index | 69 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1465-6566%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | An evaluation of pitavastatin for the treatment of hypercholesterolemia. Author: Chan P1, Shao L2, Tomlinson B3,4, Zhang Y3, Liu ZM5. Journal: Expert Opin Pharmacother. 2019 Jan;20(1):103-113. doi: 10.1080/14656566.2018.1544243. Epub 2018 Nov 27. PubMed DOI |
| 2. | Insight into the perioperative management of direct oral anticoagulants: concerns and considerations. Author: Ibrahim A1, Walsh LG2, Algaali M1, Satti Z1, Kiernan TJ3, Yan BP4. Journal: Expert Opin Pharmacother. 2019 Mar;20(4):465-472. doi: 10.1080/14656566.2018.1551879. Epub 2018 Dec 6. PubMed DOI |
| 3. | Evaluating the efficacy and safety of atorvastatin + ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia. Author: Ma YB1, Chan P2, Zhang Y3, Tomlinson B3,4, Liu Z5. Journal: Expert Opin Pharmacother. 2019 Jun;20(8):917-928. doi: 10.1080/14656566.2019.1594776. Epub 2019 Mar 25. PubMed DOI |
| 4. | Bivalirudin infusion in patients with acute coronary syndrome after stenting. Author: Li W1, Mai L1, Cai X2, Li M1, Huang Y1. Journal: Expert Opin Pharmacother. 2019 May 6:1-2. doi: 10.1080/14656566.2019.1615329. [Epub ahead of print] PubMed DOI |
| 5. | Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study. Author: Liu LP, Wang Y, Si R, Yuan M, Cheng K, Guo WY. Journal: Expert Opin Pharmacother. 2016;17(1):7-16. doi: 10.1517/14656566.2016.1110145. Epub 2015 Nov 7. PubMed |
| 6. | Combination therapy for type 2 diabetes: dapagliflozin plus metformin. Author: Tan X, Hu J. Journal: Expert Opin Pharmacother. 2016;17(1):117-26. doi: 10.1517/14656566.2016.1121235. Epub 2015 Dec 8. Review. PubMed |
| 7. | Evogliptin: a new dipeptidyl peptidase inhibitor for the treatment of type 2 diabetes. Author: Tan X, Hu J. Journal: Expert Opin Pharmacother. 2016 Jun;17(9):1285-93. doi: 10.1080/14656566.2016.1183645. Epub 2016 May 13. PubMed |
| 8. | Efficacy of hypoglycemic treatment in type 2 diabetes stratified by age or diagnosed age: a meta-analysis. Author: Cai X, Yang W, Chen Y, Gao X, Zhou L, Zhang S, Han X, Ji L. Journal: Expert Opin Pharmacother. 2016 Aug;17(12):1591-1598. Epub 2016 Jul 4. PubMed |
| 9. | A triplet chemotherapy regimen of cisplatin, fluorouracil and paclitaxel for locoregionally recurrent nasopharyngeal carcinoma cases contraindicated for re-irradiation/surgery. Author: Wang Y, Wang ZQ, Jiang YX, Wang FH, Luo HY, Liang Y, Wang DS, Li YH. Journal: Expert Opin Pharmacother. 2016 Aug;17(12):1585-1590. Epub 2016 Jun 30. PubMed |
| 10. | Efficacy of crizotinib in first-line treatment of adults with ALK-positive advanced NSCLC. Author: Zhang YC, Zhou Q, Wu YL. Journal: Expert Opin Pharmacother. 2016 Aug;17(12):1693-1701. Epub 2016 Jul 13. PubMed |
|
|
